http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2287339-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee3f2860813b1f564a1833d38bee9b7b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
filingDate 2005-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_551277a6eccad0de4dffce0906e4103e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8f26ea79be2353576764da1962d261d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2748d53a3e9287ef22ea7629428215c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cfcfe7729887fab68f1f06b5e892861
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76d2e7fb7e4c2af72755e884d79321ef
publicationDate 2006-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2287339-C1
titleOfInvention Method for obtaining preparation that contains the complex of heat shock proteins 70, 90, 96 associated with antigenous peptides
abstract FIELD: biopharmacology, preparative biochemistry and medicine. n SUBSTANCE: the method deals with homogenizing mammalian tissues and centrifuging. It is necessary to add ammonium sulfate to supernatant that contains the complex of heat shock proteins (HSP) up to 35-65% saturation, the residue developed should be dissolved in phosphate buffer at pH 7.2 followed by chromatography upon a column with sephadex G-50, then obtained protein fraction should be exposed to the action of chromatography upon heparin-sepharose. Fractions that contain TSP 70, 90, 96 the content of which was detected with the help of corresponding antibodies should be united, concentrated and salted out due to ultrafiltration. The innovation provides more simplified and shortened terms for implementing the method without applying expensive equipment. The complexes obtained should be applied in immunotherapy of oncological diseases. n EFFECT: higher efficiency. n 2 dwg, 1 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2640017-C1
priorityDate 2005-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411174055
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4684
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A286ZV08
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6U272
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ66I23
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID94241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447827115
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID297822
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4684
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE1BNK3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PI70
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24538
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCH0YX95
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458391465
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PKH2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16218782
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID60599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451761003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1R741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4329331
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1NNP2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA6QP91
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6ZYQ1

Total number of triples: 44.